← Leaderboards
Steven M Holland
Niaid Extramural Activities
$444,256
Attributed
$888,512
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $458K · FY2024–25$500K$375K$250K$125K$0
'24
'25
Funding mix
By agency
NIH$888,512 · 1
By mechanism
U01$888,512 · 1
Top collaborators
- Martin J Blaser2 shared
Most similar at Niaid Extramural Activities
Same institution · by research overlap
Others in their field
Other Rising Stars on “Human Subject”
- James Cappo · National Jewish Health$9,298,220
- Frank A Provenzano · St. Joseph'S Hospital And Medical Center$8,533,907
- Cathryn Peltz · Henry Ford Health + Michigan State University Health Sciences$7,977,678
- George Gaitanaris · Omeros Corporation$6,689,019
- Matthew Barstow · Harvard Medical School$6,000,000
- Charles Daniel Meyers · Tempero Bio, Inc.$5,310,920
Research focus
Human SubjectLaboratory MousePatient Oriented ResearchCytokineChild (0-11)Pathologic ProcessImmuneAdolescence (12-20)GenesEnzyme Linked Immunosorbent AssayTissue /Cell CultureInterferon GammaImmunomodulatorsImmunodeficiencyNonhuman Therapy EvaluationNad(P)H DehydrogenaseBactericidal ImmunityEnzyme ActivityInterleukin 12LymphocyteChronic Granulomatous DiseaseImmune ResponseCellular ImmunityGenetically Modified Animals
Grant awards (21)
Microbial, immune, metabolic perturbations by antibiotics (MIME study)$430,474
U01 · FY2025 · AI
Microbial, immune, metabolic perturbations by antibiotics (MIME study)$458,038
U01 · FY2024 · AI
Genes And Gene Products As Immunoadjuvants$2,589,919
Z01 · FY2008 · AI · contact PI
Transgenic Animal Models Of Human Immune Defects$2,184,758
Z01 · FY2008 · AI · contact PI
Genes And Gene Products As Immunoadjuvants$2,779,404
Z01 · FY2007 · AI · contact PI
Transgenic Animal Models Of Human Immune Defects$233,818
Z01 · FY2007 · AI · contact PI
Transgenic Animal Models Of Human Immune Defects$0
Z01 · FY2006 · AI · contact PI
Genes And Gene Products As Immunoadjuvants$0
Z01 · FY2006 · AI · contact PI
Genes And Gene Products As Immunoadjuvants$0
Z01 · FY2005 · AI
Transgenic Animal Models Of Human Immune Defects$0
Z01 · FY2005 · AI
Evaluation of the Inflammatory Responses Evoked by SARS$0
Z01 · FY2004 · AI
Transgenic Animal Models Of Human Immune Defects$0
Z01 · FY2004 · AI
Genes And Gene Products As Immunoadjuvants$0
Z01 · FY2004 · AI
Genes And Gene Products As Immunoadjuvants$0
Z01 · FY2003 · AI
Transgenic Animal Models Of Human Immune Defects$0
Z01 · FY2003 · AI
Genes And Gene Products As Immunoadjuvants$0
Z01 · FY2002 · AI
Transgenic Animal Models Of Human Immune Defects$0
Z01 · FY2002 · AI
Transgenic Animal Models Of Human Immune Defects$0
Z01 · FY2001 · AI
Genes And Gene Products As Immunoadjuvants$0
Z01 · FY2001 · AI
GENES AND GENE PRODUCTS AS IMMUNOADJUVANTS$0
Z01 · FY2000 · AI
TRANSGENIC ANIMAL MODELS OF HUMAN IMMUNE DEFECTS$0
Z01 · FY2000 · AI